Foghorn Therapeutics Inc.
FHTX | NASDAQ
$4.25
+$0.10 (+2.41%)
Sep 22, 2026, 11:35 AM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | -7.19M | -19.88M | -21.66M | -15.85M | -17.94M | -18.83M | -19.5M | -19.12M | -22.98M | -25.02M | -24.11M | -14.35M | -29.49M | -30.49M | -28.89M | -25.77M | -27.31M | -26.91M | -29.14M | -26.08M | -23.11M | -22.99M |
Depreciation & Amortization | 230K | 238K | 851K | 900K | 851K | 827K | 761K | 700K | 800K | 835K | 852K | 864K | 2.17M | 859K | 2.92M | 1.1M | 1.96M | 1.93M | 810K | 861K | 784K | 772K |
Stock-Based Compensation | 2.55M | 2.38M | 2.24M | n/a | 2.73M | 2.69M | 2.48M | n/a | n/a | 3.22M | 3.05M | 4.09M | n/a | 4.57M | n/a | n/a | n/a | n/a | 2.08M | 2.37M | 2.04M | 1.89M |
Other Working Capital | 7.2M | -7.2M | -9.25M | -6.83M | -6.97M | -9.57M | -8.45M | -3.88M | -8.83M | -8.62M | -8M | -18.06M | -8.42M | -8.24M | -6.33M | -316K | -5.4M | -8.03M | 35.67M | 708K | 125K | -3.2M |
Other Non-Cash Items | -21.62M | 173K | 4.5M | 3.03M | 1.07M | 631K | -141K | 2.65M | 6.3M | 865K | 900K | 673K | 3.74M | 430K | 3.21M | 3.38M | 3.18M | 3.28M | 2.48M | 1.22M | 1.18M | 1.13M |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | 7.13M | -8.19M | -8.2M | -6.94M | -7.72M | -9.28M | -8.12M | -5.23M | -9.66M | -9.25M | -8.24M | -18.5M | -8.59M | -6.55M | -6.17M | 1.31M | -6.83M | 293.24M | 35.65M | 1.12M | 620K | -3.96M |
Operating Cash Flow | -18.9M | -25.27M | -22.27M | -18.86M | -21M | -23.97M | -24.52M | -21.01M | -25.54M | -29.35M | -27.54M | -27.21M | -32.17M | -31.18M | -28.92M | -19.99M | -29.01M | 271.53M | 11.88M | -20.5M | -18.48M | -23.15M |
Capital Expenditures | -50K | n/a | n/a | n/a | -22K | -28K | -479K | -309K | -17K | -101K | -37K | -82K | -469K | -636K | -269K | -330K | -364K | -247K | -80K | -230K | -1.21M | -1.79M |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -37.08M | -66.94M | -33.98M | -4M | -42.14M | -51.12M | -39.65M | -124.45M | -66.1M | -31.26M | -6.84M | -3.86M | -36.97M | -26.23M | -44.34M | -9.62M | -143.09M | -212.29M | -10.25M | -47.1M | -16.17M | -26.47M |
Sales Maturities Of Investments | 34.17M | 49.22M | 47.21M | 39.58M | 76M | 80.55M | 62.42M | 63.45M | 48.15M | 58.46M | 44.26M | 42.37M | 76.57M | 56.37M | 38.1M | 56M | 19M | 53.13M | 20M | n/a | 94.47M | 25M |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -1K | 1K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | -2.97M | -17.72M | 13.23M | 35.57M | 33.83M | 29.4M | 22.29M | -61.32M | -17.98M | 27.1M | 37.39M | 38.43M | 39.13M | 29.51M | -6.51M | 46.05M | -124.46M | -159.41M | 9.67M | -47.33M | 77.09M | -3.26M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -21.21M | n/a | n/a | n/a |
Common Stock Repurchased | -49.77M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -22K | n/a | n/a | n/a | n/a | n/a | 4K | -390K | -195K | 1.17M | 186K | 1.39M | n/a | 102K | n/a | n/a | n/a | n/a | 42.95M | 505K | 111K | 62K |
Financial Cash Flow | -49.79M | 49.77M | 581K | 49K | 254K | 139K | 4K | 1.05M | 103.21M | 1.17M | 186K | 1.39M | 103K | 102K | 16K | 333K | 1.03M | 384K | 21.74M | 505K | 111K | 62K |
Net Cash Flow | -71.66M | 6.79M | -8.46M | 16.76M | 12.8M | 5.57M | -2.22M | -81.27M | 59.69M | -1.08M | 10.03M | 12.6M | 7.06M | -1.57M | -35.42M | 26.42M | -152.44M | 112.51M | 43.3M | -67.33M | 58.72M | -26.35M |
Free Cash Flow | -18.95M | -25.27M | -22.27M | -18.86M | -21.02M | -24M | -25M | -21.31M | -25.55M | -29.45M | -27.58M | -27.29M | -32.64M | -31.82M | -29.19M | -20.32M | -29.38M | 271.29M | 11.8M | -20.73M | -19.69M | -24.94M |
Adj. Free Cash Flow | -21.5M | -27.65M | -24.51M | -18.86M | -23.76M | -26.69M | -27.48M | -21.31M | -25.55M | -32.67M | -30.63M | -31.39M | -32.64M | -36.39M | -29.19M | -20.32M | -29.38M | 271.29M | 9.72M | -23.1M | -21.73M | -26.83M |
Maintenance CapEx | -50K | n/a | n/a | n/a | n/a | n/a | -479K | -309K | n/a | -101K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -230K | n/a | n/a |
Growth CapEx | n/a | n/a | n/a | n/a | -22K | -28K | n/a | n/a | -17K | n/a | -37K | -82K | -469K | -636K | -269K | -330K | -364K | -247K | -80K | n/a | -1.21M | -1.79M |
Owner Earnings | -18.95M | -25.27M | -22.27M | -18.86M | -21M | -23.97M | -25M | -21.31M | -25.54M | -29.45M | -27.54M | -27.21M | -32.17M | -31.18M | -28.92M | -19.99M | -29.01M | 271.53M | 11.88M | -20.73M | -18.48M | -23.15M |
Add to Watchlist
Select watchlists to add or remove FHTX